Bristol Myers Squibb Co

USPTO Trademark & Patent Filings

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"MOST: THE MELANOMA OBSERVATIONAL STUDY" 85380946	MOST: THE MELANOMA OBSERVATIONAL STUDY 2011-07-26
"ELOQUENT" 85376035	ELOQUENT 2011-07-20
"ANTELOPE" 85376024	ANTELOPE 2011-07-20
"TANGELO" 85376030	TANGELO 2011-07-20
"EPLYMULT" 85358373	EPLYMULT 2011-06-28
"EMDULATI" 85358347	EMDULATI 2011-06-28
"DUZEPLI" 85358329	DUZEPLI 2011-06-28
"MULPLICITI" 85358377	MULPLICITI 2011-06-28
"EMDUPLI" 85358352	EMDUPLI 2011-06-28
"EMDUBLEO" 85358333	EMDUBLEO 2011-06-28
"MULPLIXI" 85358380	MULPLIXI 2011-06-28
"EMDUPLY" 85358355	EMDUPLY 2011-06-28
"EMDUBLIMET" 85358336	EMDUBLIMET 2011-06-28
"MULZEMPLI" 85358384	MULZEMPLI 2011-06-28
"EMDUXIT" 85358365	EMDUXIT 2011-06-28
"EMDUBLIO" 85358340	EMDUBLIO 2011-06-28
"EMPLECHO" 85358367	EMPLECHO 2011-06-28
"EMDUBLO" 85358343	EMDUBLO 2011-06-28
"DUZEMPLI" 85358323	DUZEMPLI 2011-06-28
"COMMAND COMBINATION REGIMENS AND NS5A DEVELOPMENT IN HEPATITIS C" 85354235	COMMAND COMBINATION REGIMENS AND NS5A DEVELOPMENT IN HEPATITIS C 2011-06-23
"ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV" 85354242	ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV 2011-06-23
"MY POST TRANSPLANT NETWORK" 85343047	MY POST TRANSPLANT NETWORK 2011-06-10
"RHEUMATOLOGY COLLABORATIVE INSTITUTE" 85338557	RHEUMATOLOGY COLLABORATIVE INSTITUTE 2011-06-06
"PLICITU" 85333551	PLICITU 2011-05-31
"EMLINXITI" 85333533	EMLINXITI 2011-05-31
"DUKIXITI" 85333524	DUKIXITI 2011-05-31
"EPLURIZE" 85333536	EPLURIZE 2011-05-31
"DULIBITI" 85333526	DULIBITI 2011-05-31
"KEMPLURMET" 85333540	KEMPLURMET 2011-05-31
"DUTIXITI" 85333527	DUTIXITI 2011-05-31
"METLINXITI" 85333545	METLINXITI 2011-05-31
"EMDUXITI" 85333528	EMDUXITI 2011-05-31
"PLICIDU" 85333549	PLICIDU 2011-05-31
"EMLINXETI" 85333530	EMLINXETI 2011-05-31
"ENLIST" 4444219 85328599	ENLIST 2011-05-24
"ENLIST EVALUATING NULOJIX LONG-TERM SAFETY IN TRANSPLANT" 4444220 85328604	ENLIST EVALUATING NULOJIX LONG-TERM SAFETY IN TRANSPLANT 2011-05-24
"CML CARE - GET THE STRENGTH THAT COMES FROM KNOWLEDGE" 85320126	CML CARE - GET THE STRENGTH THAT COMES FROM KNOWLEDGE 2011-05-13
"PICOT PLUS" 85318803	PICOT PLUS 2011-05-12
"METEMPLI" 85315664	METEMPLI 2011-05-09
"TESYNPLI" 85315678	TESYNPLI 2011-05-09
"EDEMPLIC" 85315635	EDEMPLIC 2011-05-09
"EMLIMET" 85315644	EMLIMET 2011-05-09
"KOPLICIT" 85315650	KOPLICIT 2011-05-09
"DEFINE" 4070392 85311685	DEFINE 2011-05-04
"RHEUMATOLOGY COLLABORATIVE INSTITUTE" 85312082	RHEUMATOLOGY COLLABORATIVE INSTITUTE 2011-05-04
"Symbol/Image" 85310535	Symbol/Image 2011-05-03
"YOUR VOYAGE" 4292919 85307215	YOUR VOYAGE 2011-04-28
"PEBBMETO" 85301906	PEBBMETO 2011-04-22
"PEBBROLT" 85301908	PEBBROLT 2011-04-22
"PLYCIPEB" 85301909	PLYCIPEB 2011-04-22
"METLAPA" 85301141	METLAPA 2011-04-21
"KEMPLEMET" 85301078	KEMPLEMET 2011-04-21
"COZEMPLIT" 85300840	COZEMPLIT 2011-04-21
"METLICEMP" 85301152	METLICEMP 2011-04-21
"KEMPLIMET" 85301092	KEMPLIMET 2011-04-21
"DUEMPLI" 85300846	DUEMPLI 2011-04-21
"METPLITI" 85301200	METPLITI 2011-04-21
"LAPEBLI" 85301101	LAPEBLI 2011-04-21
"DULIXITI" 85300854	DULIXITI 2011-04-21
"ABEPLI" 85300825	ABEPLI 2011-04-21
"METSAPEB" 85301219	METSAPEB 2011-04-21
"MAPPEMET" 85301118	MAPPEMET 2011-04-21
"GEMPLEMET" 85300861	GEMPLEMET 2011-04-21
"APEBMET" 85300829	APEBMET 2011-04-21
"PEBBEM" 85301236	PEBBEM 2011-04-21
"METEMPLIC" 85301130	METEMPLIC 2011-04-21
"GEMPLIMET" 85300867	GEMPLIMET 2011-04-21
"APPONECT" 85300832	APPONECT 2011-04-21
"PEBBITI" 85301250	PEBBITI 2011-04-21
"ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY" 85294803	ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY 2011-04-14
"ADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS" 85294809	ADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS 2011-04-14
"ACCESS VIROLOGY" 4236007 85294845	ACCESS VIROLOGY 2011-04-14
"APPROPRIATE APIXABAN PROPHYLAXIS IN ONCOLOGY PATIENTS TO EVALUATE REDUCTION IN ADVERSE THROMBOEMBOLIC EVENTS" 85294799	APPROPRIATE APIXABAN PROPHYLAXIS IN ONCOLOGY PATIENTS TO EVALUATE REDUCTION IN ADVERSE THROMBOEMBOLIC EVENTS 2011-04-14
"MY NULOJIX NETWORK (BELATACEPT) CONNECT WITH CARE" 85291490	MY NULOJIX NETWORK (BELATACEPT) CONNECT WITH CARE 2011-04-11
"KIDNEY COLLECTIVE" 4344298 85979121	KIDNEY COLLECTIVE 2011-04-04
"KIDNEY COLLECTIVE" 85285314	KIDNEY COLLECTIVE 2011-04-04
"OBSERVE - OBSERVATIONAL BELATACEPT SAFETY REGISTRY" 85283768	OBSERVE - OBSERVATIONAL BELATACEPT SAFETY REGISTRY 2011-04-01
"CENSUS - COMPILATION OF PATIENT EXPERIENCE WITH NULOJIX FOR A SPECIFIC UNDERSTANDING OF SAFETY" 85283791	CENSUS - COMPILATION OF PATIENT EXPERIENCE WITH NULOJIX FOR A SPECIFIC UNDERSTANDING OF SAFETY 2011-04-01
"ENLIST- EVALUATING NULOJIX LONG-TERM SAFETY IN TRANSPLANT" 4656507 85283401	ENLIST- EVALUATING NULOJIX LONG-TERM SAFETY IN TRANSPLANT 2011-04-01
"B B Â· CARE PARTNER SUPPORTING THE CIRCLE OF CHB CARE" 4564477 85273278	B B Â· CARE PARTNER SUPPORTING THE CIRCLE OF CHB CARE 2011-03-22
"B" 4568577 85273288	B 2011-03-22
"GET THE STRENGTH THAT COMES FROM KNOWLEDGE" 85273429	GET THE STRENGTH THAT COMES FROM KNOWLEDGE 2011-03-22
"CML CURRENTS" 85273455	CML CURRENTS 2011-03-22
"KIND TRANSPLANT ESSENTIALS" 85273204	KIND TRANSPLANT ESSENTIALS 2011-03-22
"AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE" 85270345	AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE 2011-03-18
"WE'RE LEADING BIOPHARMA'S FUTURE. TOGETHER" 4625826 85982714	WE'RE LEADING BIOPHARMA'S FUTURE. TOGETHER 2011-03-17
"WE'RE LEADING BIOPHARMA'S FUTURE. TOGETHER" 85269259	WE'RE LEADING BIOPHARMA'S FUTURE. TOGETHER 2011-03-17
"SIMPLICITY" 4625198 85260866	SIMPLICITY 2011-03-08
"AXECTITUDE" 85259814	AXECTITUDE 2011-03-07
"MASURVO" 85259824	MASURVO 2011-03-07
"RETIGMO" 85259835	RETIGMO 2011-03-07
"AVENUE - AVAGACESTAT INVESTIGATION AND UNDERSTANDING" 85250267	AVENUE - AVAGACESTAT INVESTIGATION AND UNDERSTANDING 2011-02-24
"AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE" 85248221	AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE 2011-02-22
"APPRAISE" 85243424	APPRAISE 2011-02-16
"APPRAISE" 85243667	APPRAISE 2011-02-16
"NULOJX" 85232201	NULOJX 2011-02-02
"A-CLICK" 85229741	A-CLICK 2011-01-31
"A-CLIQ" 85229743	A-CLIQ 2011-01-31
"BECLICK" 85229744	BECLICK 2011-01-31
"CLICKJECT" 85229745	CLICKJECT 2011-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.